Licensing & Partnering for biotech, pharmaceutical and life science companies
We provide our clients with the knowledge and skills needed for choosing the right strategic partners.
Recent studies estimate that development and FDA approval of a single drug compound costs as much as USD 800 million. Strategic partnerships are key to meeting this challenge.
We assist our clients in preparing, negotiating, and selecting the right licensing and collaboration deals.
Recent Posts:
- Kapital til iværksættere
- Discount rates in drug development
- Financial valuation methods for biotechnology
- Valuation methods and discount rates in Biotech
- Important to distinguish between the short-term and longer-term effects of the credit crisis
- New Medicon Valley network at LinkedIN
- Good news for Medicon Valley
- Why the market does not like Flurizan
Licensing & Partnering
We assist our pharmaceutical, life science and biotech clients in all strategic matters relating to the development of their business, from strategy formulation, opportunity evaluation, target prioritization and partner identification to deal negotiation:
We help develop commercial and business development strategies enabling our biotech, pharma and life science clients to meet their financial and commercial targets:
- We conduct market sizing and forecasting evaluations
- We help validate the selection of in-licensing opportunities
- We conduct advance financial valuations of in-licensing and out-licensing projects
- We develop the strategic communication and business development material required to position the client company as an attractive commercial partner
- We handle evaluation of and contact to potential strategic partners
- We assist in all phases of licensing and partnering negotiations
- We provide interim management of all post-signature processes and aspects of a deal